Oral submucous fibrosis (OSF) is a serious disease that impairs mouth functionality, often leading to restricted opening and ...

Gastric cancer remains a major health challenge worldwide, with nearly 1 million new cases annually contributing to more than ...

Explore the reasons behind bumps inside lips, from small, clear to white or red, and find effective treatments and remedies ...

Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) ...

Colorectal Cancer: Immune Reprogramming and Combination ... IBD: Barrier Protection and Mucosal Homeostasis In a second oral presentation, “TP-317, a Novel BLT1 Agonist Oral Therapy for IBD ...

And this higher cancer risk was present regardless of whether ... This means they can damage the soft tissue (or oral mucosa) in the mouth over time, he explained, making cells potentially more ...

haematobium in cervical cancer, and a larger study ... with oncogenic gene expression in cervical mucosa, with enhanced effects following treatment. Oral Presentation. ESCMID Global 2025.

A new study finds that Schistosoma haematobium infection, and its treatment, can activate cancer-related genes in the cervix, ...

Privo Technologies, Inc., a clinical-stage biopharmaceutical company pioneering nanotechnology-based cancer therapies, is thrilled to announce the activation of multiple premier clinical sites across ...

Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

A two-time cancer survivor at 66, Crowell has not been able to eat solid ... While other patients may have options, she cannot take oral medications. “If Wanda’s line is clotted off and we can’t get ...